Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPCP9 is a pseudogene resembling the functional gene HNRNPC, which encodes heterogeneous nuclear ribonucleoprotein C1/C2, an RNA-binding protein involved in pre-mRNA processing, splicing, and cancer biology[1][2][3][4]. Pseudogenes like HNRNPCP9 typically do not encode active proteins and are not considered valid therapeutic targets or disease biomarkers. The confusion may arise because the parent gene HNRNPC is biologically important and implicated in multiple disease contexts, including cancer and RNA metabolism[2][4]. However, HNRNPCP9 itself lacks evidence of translational capacity, functional regulatory RNA, or disease involvement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C pseudogene 9 (HNRNPCP9).